Kamilla Miskowiak
Kamilla Miskowiak
Zugehörigkeit unbekannt
Bestätigte E-Mail-Adresse bei miskowiak.dk
Titel
Zitiert von
Zitiert von
Jahr
Bipolar disorders
E Vieta, M Berk, TG Schulze, AF Carvalho, T Suppes, JR Calabrese, ...
Nature reviews Disease primers 4 (1), 1-16, 2018
1762018
Cognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analyses
B Bortolato, KW Miskowiak, CA Köhler, E Vieta, AF Carvalho
Neuropsychiatric disease and treatment 11, 3111, 2015
1542015
Cognitive remission: a novel objective for the treatment of major depression?
B Bortolato, KW Miskowiak, CA Köhler, M Maes, BS Fernandes, M Berk, ...
BMC medicine 14 (1), 9, 2016
1272016
Erythropoietin enhances hippocampal response during memory retrieval in humans
K Miskowiak, U O'Sullivan, CJ Harmer
Journal of Neuroscience 27 (11), 2788-2792, 2007
1032007
Is there an association between subjective and objective measures of cognitive function in patients with affective disorders?
AM Svendsen, LV Kessing, K Munkholm, M Vinberg, KW Miskowiak
Nordic journal of psychiatry 66 (4), 248-253, 2012
992012
Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration
K Miskowiak, B Inkster, S Selvaraj, R Wise, GM Goodwin, CJ Harmer
Neuropsychopharmacology 33 (3), 611-618, 2008
902008
Recombinant human erythropoietin for treating treatment-resistant depression: a double-blind, randomized, placebo-controlled phase 2 trial
KW Miskowiak, M Vinberg, EM Christensen, JD Bukh, CJ Harmer, ...
Neuropsychopharmacology 39 (6), 1399-1408, 2014
892014
Cognitive dysfunction in depression–pathophysiology and novel targets
A F Carvalho, K K Miskowiak, T N Hyphantis, C A Kohler, G S Alves, ...
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2014
762014
Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force
KW Miskowiak, KE Burdick, A Martinez‐Aran, CM Bonnin, CR Bowie, ...
Bipolar disorders 19 (8), 614-626, 2017
742017
Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial
KM Demant, M Vinberg, LV Kessing, KW Miskowiak
PLoS One 10 (6), e0127955, 2015
682015
Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
KW Miskowiak, M Vinberg, CJ Harmer, H Ehrenreich, LV Kessing
Psychopharmacology 219 (3), 687-698, 2012
662012
Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial
KW Miskowiak, H Ehrenreich, EM Christensen, LV Kessing, M Vinberg
The Journal of clinical psychiatry 75 (12), 1347-1355, 2014
652014
Screening for cognitive dysfunction in unipolar depression: validation and evaluation of objective and subjective tools
CV Ott, AJ Bjertrup, JH Jensen, H Ullum, R Sjælland, SE Purdon, E Vieta, ...
Journal of Affective Disorders 190, 607-615, 2016
632016
Discrete neurocognitive subgroups in fully or partially remitted bipolar disorder: Associations with functional abilities
JH Jensen, U Knorr, M Vinberg, LV Kessing, KW Miskowiak
Journal of affective disorders 205, 378-386, 2016
622016
Single dose antidepressant administration modulates the neural processing of self-referent personality trait words
K Miskowiak, M Papadatou-Pastou, PJ Cowen, GM Goodwin, R Norbury, ...
Neuroimage 37 (3), 904-911, 2007
582007
Effects of erythropoietin on hippocampal volume and memory in mood disorders
KW Miskowiak, M Vinberg, J Macoveanu, H Ehrenreich, N Køster, ...
Biological psychiatry 78 (4), 270-277, 2015
562015
Systemic oxidatively generated DNA/RNA damage in clinical depression: associations to symptom severity and response to electroconvulsive therapy
A Jorgensen, J Krogh, K Miskowiak, TG Bolwig, LV Kessing, ...
Journal of affective disorders 149 (1-3), 355-362, 2013
562013
Erythropoietin reduces neural and cognitive processing of fear in human models of antidepressant drug action
K Miskowiak, U O’Sullivan, CJ Harmer
Biological psychiatry 62 (11), 1244-1250, 2007
562007
Bias in emerging biomarkers for bipolar disorder
AF Carvalho, CA Köhler, BS Fernandes, J Quevedo, KW Miskowiak, ...
Psychological medicine 46 (11), 2287-2297, 2016
542016
Erythropoietin improves place learning in fimbria–fornix-transected rats and modifies the search pattern of normal rats
J Mogensen, K Miskowiak, TA Sørensen, CT Lind, NV Olsen, ...
Pharmacology Biochemistry and Behavior 77 (2), 381-390, 2004
532004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20